Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Dermatitis and Phase III Drugs-Global API Manufacturers Overview, Forecast & Comparative Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) Report, "Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of...

Source: EmailWire.com

Cognitive Impairment Associated With Schizophrenia Overview, Forecast & Comparative Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) " Cognitive Impairment Associated With Schizophrenia (CIAS)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Cognitive Impairment Associated With Schizophrenia (CIAS). The Report...

Source: EmailWire.com

30S Ribosomal Subunit Inhibitors Overview and Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) Publisher's, "30S Ribosomal Subunit (30S RNA) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the 30S Ribosomal Subunit (30S RNA) Inhibitors. The Publisher's Report covers...

Source: EmailWire.com

N-Cadherin Protein Antagonists Overview, Forecast & Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) "N-Cadherin Protein Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the N-Cadherin Protein Antagonists. The Report covers the product profiles in various stages of development...

Source: EmailWire.com

Lower Respiratory Tract Infections and Phase III Drugs-Global API Manufacturers Overview, Forecast & Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) Report, "Lower Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe....

Source: EmailWire.com

Ankylosing Spondylitis and Phase III Drugs-Global API Manufacturers Overview, Forecast & Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) Report, "Ankylosing Spondylitis (Bekhterev's Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross...

Source: EmailWire.com

Farnesyl Diphosphate Synthase Inhibitors Overview, Forecast & Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) Publisher's, "Farnesyl Diphosphate Synthase (FPPS) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Farnesyl Diphosphate Synthase (FPPS) Inhibitors. The Publisher's...

Source: EmailWire.com

Rabies Therapeutics under Development by Companies Overview, Forecast & Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) " Rabies-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Rabies. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND,...

Source: EmailWire.com

Anti-CD22 Antibody Therapeutics under Development by Companies Overview, Forecast & Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) Publisher's, "Anti-CD22 Antibody-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD22 Antibody. The Publisher's Report covers the product profiles in various stages of development...

Source: EmailWire.com

Menopausal Hot Flashes Therapeutics under Development by Companies Overview, Forecast & Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) " Menopausal Hot Flashes-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Menopausal Hot Flashes. The Report covers the product profiles in various stages of development including...

Source: EmailWire.com

Indolent Lymphoma Therapeutics under Development by Companies Overview, Forecast & Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) " Indolent Lymphoma-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Indolent Lymphoma. The Report covers the product profiles in various stages of development including Discovery,...

Source: EmailWire.com

Tumor Necrosis Factor Alpha Agonists Overview, Forecast & Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) "Tumor Necrosis Factor Alpha (TNF-a) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Tumor Necrosis Factor Alpha (TNF-a) Agonists. The Report covers the product profiles...

Source: EmailWire.com

Gastric Cancer and Phase III Drugs-Global API Manufacturers Overview, Forecast & Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) Report, "Gastric Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective...

Source: EmailWire.com

11 Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Technology Trend, Competitive Forecast & Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) Publisher's, "11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11HSD1) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11HSD1)...

Source: EmailWire.com

5-HT4 Agonists Overview and Analysis 2016

(Medical-NewsWire.com, September 04, 2017 ) Publisher's, "5-HT4 Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the 5-HT4 Agonists. The Publisher's Report covers the product profiles in various stages of development...

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC